Health Care & Life Sciences » Pharmaceuticals | Aralez Pharmaceuticals Inc.

Aralez Pharmaceuticals Inc. | Income Statement

Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
Sales/Revenue
10,322.00
32,394.20
21,391.40
54,270.00
105,947.00
Cost of Goods Sold (COGS) incl. D&A
-
-
-
24,356.00
47,829.00
Gross Income
-
-
-
29,914.00
58,118.00
SG&A Expense
27,076.40
15,799.70
47,341.20
109,605.00
118,896.00
EBIT
16,783.90
16,575.60
25,966.10
79,691.00
60,778.00
Unusual Expense
-
2,678.80
11,500.00
18,149.00
35,701.00
Non Operating Income/Expense
-
-
199.00
939.00
658.00
Interest Expense
-
-
-
6,141.00
26,984.00
Pretax Income
16,708.30
19,674.70
37,609.10
103,042.00
122,805.00
Income Tax
-
-
174.40
64.00
2,400.00
Consolidated Net Income
16,708.30
19,674.70
37,783.40
102,978.00
125,205.00
Net Income
16,708.30
19,674.70
37,783.40
102,978.00
125,205.00
Net Income After Extraordinaries
16,708.30
19,674.70
37,783.40
102,978.00
125,205.00
Net Income Available to Common
16,708.30
19,674.70
37,783.40
102,978.00
125,205.00
EPS (Basic)
0.54
0.60
1.16
1.74
1.89
Basic Shares Outstanding
-
31,359.90
32,589.80
61,831.00
66,389.00
EPS (Diluted)
-
0.60
1.16
1.74
1.89
Diluted Shares Outstanding
-
32,810.60
32,589.80
61,883.00
66,389.00
EBITDA
16,754.50
16,594.50
25,949.80
66,723.00
24,977.00
Non-Operating Interest Income
75.60
420.30
56.00
-
-

About Aralez Pharmaceuticals

View Profile
Address
7100 West Credit Avenue
Mississauga Ontario L5N 0E4
Canada
Employees -
Website http://www.aralez.com
Updated 09/14/2018
Aralez Pharmaceuticals Inc. focuses on the development, acquisition, and commercialization of cardiovascular, pain, and other product therapies. It operates through the foolowing geographical segments: United States, and Canada. The company is founded on December 2, 2015 and is headquartered in Ontario, Canada.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.